Year :
2022
| Month :
December
| Volume :
16
| Issue :
12
| Page :
OD06 - OD08
Full Version
Recurrent Right-side Pleural Effusion Mimicking Malignancy: Pseudo-Meig’s Syndrome
Published: December 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/60073.17283
Bhavesh Patel, Princee Patel, Arti Shah, Chirag Chakravarti
1. Associate Professor, Department of Respiratory Medicine, Smt. B.K. Shah Medical Institute and Research Centre, Vadodara, Gujarat, India.
2. Postgraduate Resident, Department of Respiratory Medicine, Smt. B.K. Shah Medical Institute and Research Centre, Vadodara, Gujarat, India.
3. Professor and Head, Department of Respiratory Medicine, Smt. B.K. Shah Medical Institute and Research Centre, Vadodara, Gujarat, India.
4. Assistant Professor, Department of Respiratory Medicine, Smt. B.K. Shah Medical Institute and Research Centre, Vadodara, Gujarat, India.
Correspondence Address :
Dr. Princee Patel,
B/31, OM Nagar Society, Kosad Road, Amroli, Surat, Gujarat, India.
E-mail: princee.patel97@gmail.com
Abstract
Pseudo-Meig’s syndrome is an unusual presentation in which a benign ovarian tumour develops with ascites and pleural effusion. Diagnosis of exclusion is made only after ovarian fibroma has been ruled out and confirmed by disappearance of pleural effusion. The present case report is of a 55-year-old female, who presented with progressive shortness of breath, on and off right chest pain, and abdominal distension, over a period of 2-3 months. Clinical examination and a chest radiograph confirmed pleural effusion as the cause of progressive dyspnea. Presence of a pelvic mass and an elevated serum Cancer Antigen-125 (CA-125) increased the probability of malignancy. After complete tumour resection, a pathological report confirmed a benign ovarian tumour. The authors highlight the importance of suspicion, careful general examination, radiological evaluation, and histologic examination to confirm the diagnosis of pseudo-Meig’s syndrome.
Keywords
Cancer antigen 125, Ovarian fibroma, Struma ovarii
Case Report
A 55-year-old postmenopausal female presented with chief complaints of progressive shortness of breath, right sided chest pain on and off and abdominal distension past 2-3 months. She had a history of recurrent right-sided pleural effusion and underwent repeated thoracocentesis. The vitals were stable and she was maintaining SpO2 98% on room air.
On auscultation, decreased intensity of breath sound was noted in right interscapular, infrascapular and infra-axillary areas. Chest radiograph Posteroanterior (PA) view showed right-sided homogenous opacity in mid and lower zone with right-sided Costophrenic (CP) angle blunted (Table/Fig 1).
The patient was admitted, blood haemograms, Renal Function Test (RFT), Liver Function Test (LFT) were normal. Human Immunodeficiency Virus (HIV), Hepatitis B surface Antigen (HBsAg), Hepatitis C Virus (HCV) was non reactive and total serum protein was 6.1 gm/dL. Ultrasonography (USG) of thorax with abdomen and pelvis was suggestive of moderate right-sided pleural effusion, moderate ascites with hepatomegaly and heterogenous hypoechoic lesion of size 54×76 mm noted in right adnexa with cystic necrotic area within. A right adnexal neoplastic lesion with ovarian malignant neoplasm was likely.
Contrast Enhanced Computed Tomography (CECT) abdomen and pelvis with thorax screening showed right-sided moderate pleural effusion (Table/Fig 2), moderate ascites with hepatomegaly and a well-defined heterogeneously enhancing soft tissue density lesion measuring 10×8 cm involving left ovary with cystic component within (Table/Fig 3). Further blood investigations revealed, normal thyroid function test {Triiodothyronine (T3), Thyroxine (T4), Thyroid Stimulating Hormone (TSH)} but elevated Cancer Antigen-125 (CA-125) level (425 U/mL).
A therapeutic and diagnostic thoracocentesis and paracentesis were performed to alleviate symptoms- both pleural and ascitic fluids were sent for routine microscopy and cytology. The pleural fluid examination report suggested exudative pleural effusion according to Light’s criteria (pleural fluid protein/serum protein) (1).
The ascitic fluid examination is detailed in (Table/Fig 4). The Serum to Ascitic Albumin Gradient (SAAG ratio 1.1 g/L) points to the presence of exudative ascitic fluid.
The patient was referred to a gynaecologist for further management. A total abdominal hysterectomy with bilateral salpingo-oopherectomy was performed. The left ovarian mass, sent for histopathological examination, was suggestive of mature cystic teratoma with dominant areas of struma ovarii showing thyroid follicles of varying size (Table/Fig 5). The patient made an uneventful recovery and discharged on 10th postoperative day. After eight weeks on follow-up she was clinically and physically well with no evidence of diseases and normal CA-125 level (14.7 U/mL).
When she was examined a year later, she was still free of disease clinically and radiologically. Her follow-up chest radiograph posteroanterior view did not show any signs of pleural effusion, and her bilateral CP angles were clear (Table/Fig 6). Her USG abdomen and pelvis revealed borderline hepatomegaly but no evidence of ascites.
Discussion
In 1937, Meigs and Cass first reported a series of cases in a patient with ascites, pleural effusion, and ovarian fibroma (2). Meigs’ syndrome is classically described as a triad of benign solid ovarian tumour with the gross appearance of a fibroma (either a fibroma, thecoma, or granulosa cell tumour) along with pleural effusion, ascites and resolution of effusion, ascites after tumour removal (3). In contrast, pseudo-Meig’s syndrome presents with ascites and pleural effusion, but with other pelvic masses (4) including mature teratoma, struma ovarii and ovarian, fallopian tube or uterine leiomyoma (5).
Meigs syndrome and pseudo-Meigs syndrome are very rare disorders. Meigs syndrome occurs in about 1% of all ovarian fibroids, uterine fibroids, and granulomas. Ovarian fibroid, ascites, and pleural effusion have been reported in 10-15% and 1% of cases, respectively (6).
Struma ovarii mimicking advanced ovarian cancer can be difficult to diagnose preoperatively (7). Diagnosis of struma ovarii can simplest be made with the aid of using accomplishing histopathology (8). This report focuses on a patient with struma ovarii who was initially thought to have a malignant tumour of the ovary before surgery based on clinical and radiological findings as well as elevated CA-125 levels. However, frozen sections and final histopathological reports showed a benign struma ovarii. In both syndromes, paracentesis and thoracentesis can be done to relieve symptoms, but treatment focuses on surgical removal of the tumour. If ascites and pleural effusion resolve and do not reaccumulate, a retrospective diagnosis can be made.
Struma ovarii mainly occurs during the 5th to 6th decade of life, with most cases being in postmenopausal women. The reported mean size of the tumour was 10 cm at its longest, mostly as a unilateral solid mass. They can sometimes be bilateral and contain cystic component. Malignant transformation of components is noted in 5-37% of struma, with metastases reported in less than 10% (9). The index patient presented in 5th to 6th decade of life with an unilateral left sided ovarian lesion of size 10 cm in its largest dimension containing cystic component without metastasis.
The union of ascites, pleural effusion, and ovarian tumours in postmenopausal women with elevated CA-125 increases the likelihood of ovarian malignancy.
Even though there is a correlation between CA-125 and ovarian cancer, elevated CA-125 levels are commonly seen in some benign cases of Meigs syndrome. It is a non specific tumour marker and should not be used for the diagnosis of malignant ovarian tumours. There are other diseases associated with elevated CA-125 levels, including endometriosis, cirrhosis, pelvic inflammatory disease, and uterine fibroids. The exact reason for CA-125 elevation in Meigs and pseudo-Meigs syndrome remains unclear. One viable explanation is the subsequential irritation and inflammation of the pleural and peritoneal surfaces due to the presence of free fluid in these compartments (8). In this report too the patient had an elevated CA-125 preoperatively which dropped down to normal after resection.
Several hypotheses has been proposed to explain the origin of ascites and pleural effusion in Meigs syndrome and pseudo-Meigs syndrome; although but it seems to be associated with lymphatic congestion but the exact cause remains unknown. Pressure from the tumour on lymphatic system can cause fluid to leak through the superficial lymphatic system (10),(11).
A combination of intertumoral fluid leakage, mechanical irritation from the tumour, and inflammation of the peritoneum can result in ascites. For pleural effusions, mechanical transport of ascites via diaphragmatic orifices or lymphatics has been suggested (11),(12),(13),(14). Pleural effusions in Meigs syndrome and pseudo-Meigs syndrome have also been suggested to be on the right side. This is because the transdiaphragmatic lymphatics have a larger diameter on the right side. However, left-sided and bilateral pleural effusions have been reported (15). Although ascites cytology can detect malignant cells in most of the cases, but has a high false-negative rate (16). The index patient also presented with right-sided pleural effusion and ascites, but no cytologic atypia and no evidence of pleuroperitoneal connection in CECT Thorax.
Thyroid tissue is the major component of struma ovarii, and while various signs and symptoms of hyperthyroidism occur in 7% of patients, where on other side 25-33% have asymptomatic thyroid function test abnormalities (9). After resection of benign struma ovarii Clinical hypothyroidism has additionally been reported (17). In the present case, the preoperative thyroid function tests were normal, but the histopathology of the left ovary showed a mature cystic teratoma with dominant regions of struma ovaii showing thyroid cysts of varying size. However, there were no signs of hypothyroidism even after tumour resection has been noted.
The prognosis for this condition is excellent, with resection of the underlying tumour resolving both ascites and pleural effusions within a week. In the present case report, the patient’s symptoms disappeared after surgery.
Conclusion
Complete remission of ascites, hydrothorax and CA-125 occurred after surgery. Though, the combination of these cardinal features i.e, ovarian tumour, ascites and pleural effusion is highly suspicious for ovarian cancer in postmenopausal woman, rarely they can be of benign origin. Hence, Pseudo-Meig’s syndrome should be considered in the differential diagnosis of patients presenting with suspicious clinical features but negative cytology.
Reference
| 1. | Light RW, MacGregor MI, Luchsinger PC, Ball WC Jr. pleural effusions: The diagnostic separation of transudate and exudates. Ann Intern Med. 1972;77(4):507-513.
[ CrossRef] [ PubMed] | 2. | Meigs JV. Fibroma of the ovary with ascites and hydrothorax; Meigs’ syndrome. Am J Obstet Gynecol. 1954;67(5):962-85. Doi: 10.1016/0002-9378(54)90258-6.
[ CrossRef] [ PubMed] | 3. | Okuda K, Noguchi S, Narumoto O, Ikemura M, Yamauchi Y, Tanaka G, et al. A case of Meigs’ syndrome with preceding pericardial effusion in advance of pleural effusion. BMC Pulm Med. 2016,10:71. Doi: 10.1186/s12890-016-0241-1.
[ CrossRef] [ PubMed] | 4. | Meigs JV. Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol. 1954;3(5):471-86.
[ CrossRef] [ PubMed] | 5. | Williamson JG, Patel D, Menzies DN. Leiomyomata of the uterus associated with ascites and hydrothorax. J Obstet Gynaecol Br Commonw. 1972;79(3):273-80.
[ CrossRef] [ PubMed] | 6. | Saha S, Robertson M. Meigs’ and Pseudo-Meigs’ syndrome. Australas J Ultrasound Med. 2012;15(1):29-31.
[ CrossRef] [ PubMed] | 7. | Jiang W, Lu X, Zhu ZL, Liu XS, Xu CJ. Struma ovarii associated with pseudo- Meigs’ syndrome and elevated serum CA 125: A case report and review of the literature. J Ovarian Res. 2010;3:18.
[ CrossRef] [ PubMed] | 8. | Mui MP, Tam KF, Tam FK, Ngan HY. Coexistence of struma ovarii with marked ascites and elevated CA-125 levels: Case report and literature review. Archives of gynecology and obstetrics. 2009;279(5):753-57. https://doi.org/10.1007/ s00404-008-0794-1.
[ CrossRef] [ PubMed] | 9. | Fenton BW, Barnes W. Struma ovarii. Available at: http://www. emedicine.com/ med/topic2191.htm.
| 10. | Nagakura S, Shirai Y, Hatakeyama K. Pseudo-Meigs’ syndrome caused by secondary ovarian tumors from gastrointestinal cancer: A case report and review of the literature. Dig Surg. 2000;17(4):418-19. Doi: 10.1159/000018893.
[ CrossRef] [ PubMed] | 11. | Mitrou S, Manek S, Kehoe S. Cystic struma ovarii presenting as pseudo-Meigs’ syndrome with elevated CA125 levels: A case report and review of the literature. Int J Gynecol Cancer. 2008;18(2):372-75. Doi: 10.1111/j.1525-1438.2007.00998.
[ CrossRef] [ PubMed] | 12. | Chandanwale SS, Pal SS, Kumar HB, Sammi AB. Serous cystadenoma and fibrothecoma: A rare combination in collision tumor of ovary with pseudo-Meigs syndrome. J Pathol Transl Med. 2015;49(2):163-66. Doi: 10.4132/jptm.2013.11.25.
[ CrossRef] [ PubMed] | 13. | Weise M, Westphalen S, Fayyazi A, Emons G, Krauss T. Pseudo-Meigs syndrome: Uterine leiomyoma with bladder attachment associated with ascites and hydrothorax- A rare case of a rare syndrome. Onkologie. 2002;25(5):443-46. Doi: 10.1159/000067439.
[ CrossRef] [ PubMed] | 14. | Huh JJ, Montz FJ, Bristow RE. Struma ovarii associated with pseudo-Meigs’ syndrome and elevated serum CA 125. Gynecol Oncol. 2002;86(2):231-34. Doi: 10.1006/gyno.2002.6741.
[ CrossRef] [ PubMed] | 15. | Kazanov L, Ander DS, Enriquez E, Jaggi FM. Pseudo-Meigs’ syndrome. Am J Emerg Med. 1998;16(4):404-05. Doi: 10.1016/s0735-6757(98)90141-3.
[ CrossRef] [ PubMed] | 16. | Karoo R, Lloyd T, Garcea G, Redway H, Robertson G. How valuable is ascitic cytology in the detection and management of malig- nancy? Postgrad Med J. 2003;79(931):292-94.
[ CrossRef] [ PubMed] | 17. | Carvalho JP, Carvalho FM, Lima de Oliveira FF, Asato de Camargo RY. Hypothyroidism following struma ovarii tumour resection: A case report. Rev Hosp Clin Fac Med Sao Paulo. 2002;57(3):112-14. [ CrossRef] [ PubMed] |
DOI: 10.7860/JCDR/2022/60073.17283
Date of Submission: Sep 05, 2022
Date of Peer Review: Oct 12, 2022
Date of Acceptance: Nov 29, 2022
Date of Publishing: Dec 01, 2022
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Sep 28, 2022
• Manual Googling: Oct 04, 2022
• iThenticate Software: Nov 28, 2022 (16%)
ETYMOLOGY: Author Origin
|